Talaspayeva is adding her own advancements to the field. Her master’s capstone project focuses on anti-VEGF treatment, a ...

Kodiak Sciences (KOD) added ~33% in the premarket on Thursday after the company announced that a Phase 3 trial for its eye disorder therapy, Zenkuda, reached key goals in patients with diabetic ...

Tirzepatide use was associated with a reduced 12-month risk for diabetic retinopathy incidence and worsening events vs lifestyle intervention alone. HealthDay News — For patients with diabetes and ...

Tirzepatide also linked to fewer complications, including those requiring interventions, compared with lifestyle intervention alone. (HealthDay News) — For patients with diabetes and overweight or ...

The treatment of diabetic retinopathy (DR) and diabetic macular edema (DME) has evolved significantly since the introduction of first effective treatments 50 years ago. Like with any disease, ...

Individuals with type 2 diabetes — with or without retinopathy — had higher risks for incident Alzheimer’s disease and dementia than those without the blood sugar disorder. Among patients with ...

Share on Pinterest Tirzepatide may help lower the risk of diabetic retinopathy, a diabetes complication that can lead to vision loss. Douglas Sacha/Getty Images Weight loss medications Mounjaro and ...

The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell ...

Feb 10 (Reuters) - U.S. pipeline operator Williams Companies (WMB.N), opens new tab on Tuesday forecast 2026 profit above analysts' expectations as new pipeline and offshore projects drive growth and ...

Tear fluid is emerging as an attractive source of diagnostic information because it can be collected easily and non-invasively. Changes in tear composition often reflect underlying physiological ...

BioMed X, a Heidelberg, Germany-based innovation hub for pharma, launched its first research project in partnership with the Government of Barbados and with support from the European Union’s ...

A higher incidence of new diabetic retinopathy has previously been reported in patients using GLP-1 receptor agonists. A new retrospective study suggested that use of tirzepatide was tied to a reduced ...